SkinBioTherapeutics plc (AIM:SBTX)
London · Delayed Price · Currency is GBP · Price in GBX 9.88
-0.38 (-3.66%)
Aug 14, 2026, 4:29 PM GMT
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 25.59 million as of August 14, 2026. Its market cap has decreased by -35.68% in one year.
Market Cap
25.59M
Enterprise Value
23.41M
Revenue
5.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.88
ChartMarket Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 25.59M, an increase of 62.71%. That is a compound annual growth rate of 5.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 25.59M | -37.21% |
| Dec 31, 2025 | 40.76M | -3.56% |
| Dec 31, 2024 | 42.26M | 45.57% |
| Dec 29, 2023 | 29.03M | 8.17% |
| Dec 30, 2022 | 26.84M | -59.24% |
| Dec 31, 2021 | 65.85M | 79.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Poolbeg Pharma | 66.04M |
| hVIVO | 46.03M |
| Hemogenyx Pharmaceuticals | 43.18M |
| Sareum Holdings | 35.33M |
| ImmuPharma | 23.08M |
| Arecor Therapeutics | 22.47M |
| IXICO | 16.35M |
| Aptamer Group | 15.55M |